Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117252114> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2117252114 endingPage "189" @default.
- W2117252114 startingPage "189" @default.
- W2117252114 abstract "This open label, multicentric, comparative clinical trial was done to compare the efficacy and tolerability of two sevelamer formulations, sevelamer carbonate, and sevelamer hydrochloride, in the treatment of hyperphosphatemia in Indian end stage renal disease (ESRD) patients. A total of 97 ESRD patients on hemodialysis, were enrolled. Patients were randomized to receive either sevelamer carbonate or sevelamer hydrochloride. All patients were evaluated every week for 6 weeks for efficacy and safety variables. Total 88 patients completed the study. After 6 weeks of therapy, there were similar reductions (P<0.0001) in mean serum phosphorus and the CaxP product both the groups. The responder rates for test and reference groups were 75%, 68.18% respectively (P=0.3474). The adverse events reported were nausea, abdominal pain/discomfort, heartburn, constipation, diarrhea, increased prothrombin time, and severe arthritis. No serious adverse events were reported. There was no significant difference between the groups for adverse events and the laboratory parameters. From the results of this multicentric, comparative, randomized clinical study on sevelamer carbonate we can recommend that sevelamer carbonate may be used as a phosphate binder in Indian chronic kidney disease patients." @default.
- W2117252114 created "2016-06-24" @default.
- W2117252114 creator A5022544001 @default.
- W2117252114 creator A5024506985 @default.
- W2117252114 creator A5025918615 @default.
- W2117252114 creator A5028266840 @default.
- W2117252114 creator A5033456960 @default.
- W2117252114 creator A5037155360 @default.
- W2117252114 creator A5070684841 @default.
- W2117252114 creator A5078997205 @default.
- W2117252114 date "2012-01-01" @default.
- W2117252114 modified "2023-09-27" @default.
- W2117252114 title "Sevelamer carbonate experience in Indian end stage renal disease patients" @default.
- W2117252114 cites W1977303973 @default.
- W2117252114 doi "https://doi.org/10.4103/0971-4065.98754" @default.
- W2117252114 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3459522" @default.
- W2117252114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23087553" @default.
- W2117252114 hasPublicationYear "2012" @default.
- W2117252114 type Work @default.
- W2117252114 sameAs 2117252114 @default.
- W2117252114 citedByCount "5" @default.
- W2117252114 countsByYear W21172521142014 @default.
- W2117252114 countsByYear W21172521142016 @default.
- W2117252114 countsByYear W21172521142018 @default.
- W2117252114 crossrefType "journal-article" @default.
- W2117252114 hasAuthorship W2117252114A5022544001 @default.
- W2117252114 hasAuthorship W2117252114A5024506985 @default.
- W2117252114 hasAuthorship W2117252114A5025918615 @default.
- W2117252114 hasAuthorship W2117252114A5028266840 @default.
- W2117252114 hasAuthorship W2117252114A5033456960 @default.
- W2117252114 hasAuthorship W2117252114A5037155360 @default.
- W2117252114 hasAuthorship W2117252114A5070684841 @default.
- W2117252114 hasAuthorship W2117252114A5078997205 @default.
- W2117252114 hasBestOaLocation W21172521142 @default.
- W2117252114 hasConcept C126322002 @default.
- W2117252114 hasConcept C141071460 @default.
- W2117252114 hasConcept C197934379 @default.
- W2117252114 hasConcept C2776036575 @default.
- W2117252114 hasConcept C2777425297 @default.
- W2117252114 hasConcept C2778063415 @default.
- W2117252114 hasConcept C2778375690 @default.
- W2117252114 hasConcept C2778653478 @default.
- W2117252114 hasConcept C3019040382 @default.
- W2117252114 hasConcept C71924100 @default.
- W2117252114 hasConcept C90924648 @default.
- W2117252114 hasConceptScore W2117252114C126322002 @default.
- W2117252114 hasConceptScore W2117252114C141071460 @default.
- W2117252114 hasConceptScore W2117252114C197934379 @default.
- W2117252114 hasConceptScore W2117252114C2776036575 @default.
- W2117252114 hasConceptScore W2117252114C2777425297 @default.
- W2117252114 hasConceptScore W2117252114C2778063415 @default.
- W2117252114 hasConceptScore W2117252114C2778375690 @default.
- W2117252114 hasConceptScore W2117252114C2778653478 @default.
- W2117252114 hasConceptScore W2117252114C3019040382 @default.
- W2117252114 hasConceptScore W2117252114C71924100 @default.
- W2117252114 hasConceptScore W2117252114C90924648 @default.
- W2117252114 hasIssue "3" @default.
- W2117252114 hasLocation W21172521141 @default.
- W2117252114 hasLocation W21172521142 @default.
- W2117252114 hasLocation W21172521143 @default.
- W2117252114 hasLocation W21172521144 @default.
- W2117252114 hasOpenAccess W2117252114 @default.
- W2117252114 hasPrimaryLocation W21172521141 @default.
- W2117252114 hasRelatedWork W113810927 @default.
- W2117252114 hasRelatedWork W1567135211 @default.
- W2117252114 hasRelatedWork W1966784678 @default.
- W2117252114 hasRelatedWork W2098122721 @default.
- W2117252114 hasRelatedWork W2547312728 @default.
- W2117252114 hasRelatedWork W3033781205 @default.
- W2117252114 hasRelatedWork W3129969566 @default.
- W2117252114 hasRelatedWork W40023729 @default.
- W2117252114 hasRelatedWork W4214856056 @default.
- W2117252114 hasRelatedWork W4313055595 @default.
- W2117252114 hasVolume "22" @default.
- W2117252114 isParatext "false" @default.
- W2117252114 isRetracted "false" @default.
- W2117252114 magId "2117252114" @default.
- W2117252114 workType "article" @default.